Program to Improve High Blood Pressure Care in Africa
Tests a bundle of care programs to help adults with high blood pressure in Africa.
Plain-language title generated from the registry record
Registry title: Addressing Hypertension Care in Africa Program
Key facts
- Where
- Akure, Ondo, and Owo, NigeriaSee the 6 sites
Could this be for you?
Answer for yourself. This is not a decision: only the study team can say whether you can take part.
- Are you between 18 and 70 years old?
Source: NCT06986590, who can take part
Where in Nigeria
- Akure South HospitalAkure, NigeriaTaking people
- Akoko North EastOndo, NigeriaNot yet recruiting
- Akoko North WestOndo, NigeriaNot yet recruiting
- Akoko South EastOndo, NigeriaNot yet recruiting
- Akoko South WestOndo, NigeriaNot yet recruiting
- Owo General HospitalOwo, NigeriaNot yet recruiting
Questions to ask the study team
- How often do I need to come in, and for how long each time?
- Are travel costs paid?
- Can I keep my own doctor?
- What happens if I want to stop?
Trial details
- Who runs it
- Johns Hopkins University
- Trial code
- NCT06986590
- Record updated
- 14 January 2026
- Original description
The ADHINCRA Program is a bundle of multilevel evidence-based interventions that address multiple predictors of controlled hypertension, including patient-, provider-, and health system-level factors. The successful implementation of the ADHINCRA program will provide a rigorous and scalable model for improving hypertension control in Africa, which would ultimately reduce the risk of cardiovascular disease, stroke and kidney disease.Read full original descriptionShow less
Addressing Hypertension Care in Africa (ADHINCRA) Program
The ADHINCRA Program is a bundle of multilevel evidence-based interventions that address multiple predictors of controlled hypertension, including patient-, provider-, and health system-level factors. The successful implementation of the ADHINCRA program will provide a rigorous and scalable model for improving hypertension control in Africa, which would ultimately reduce the risk of cardiovascular disease, stroke and kidney disease.
Inclusion: Aged 18 -70 years; Diagnosis of hypertension and elevated systolic blood pressure measure (≥140 mmHg) on the most recent clinic visit without a diabetes diagnosis; Hypertension treatment naive or on monotherapy; Receives primary care at one of the participating sites; Willing and able to provide informed consent in English, Twi, Dagbani, Ewe, Hausa, or Yoruba; Owns a smartphone (Android or iOS).
Exclusion: Diagnosis of end-stage renal disease (ESRD) treated with dialysis; Diagnosis of stroke, coronary artery disease, or kidney disease; Serious medical condition which either limits life expectancy or requires active management (e.g., cancer); Cognitive impairment or other conditions preventing study participation; Age <18 years or >70 years; Severely elevated BP (≥180/110mmHg); Pregnant or currently nursing a child; Unwilling to provide informed consent.